ERBB2 and cancer: For a better comparability of cases, we then refined the patient collective for the following analyses and only included patients with primary cancers that were unifocal, estrogen receptor-positive, Her2-negative with an age ≤ 70 years (n = 3744), as these factors represent the majority of breast cancer characteristics in our cohort.